drugset / Trial / NCT01324362

GSK BHR Study (Sont - Second Study)

NCT01324362

Phase 4 Completed 446 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study was to determine whether asthma control and reduced bronchial responsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS BID or FP BID in adult and adolescent patients with persistent asthma

Timeline

Start
2003-01
Primary completion
2004-10
Completion
2004-10

Publications

  • Background Stauffer JL, Yancey SW, Baitinger LA, Prillaman BA, Dorinsky PM. Measuring airway hyperresponsiveness: Does it add to routine measures of clinical efficacy in guiding asthma therapy? Proc Am Thorac Soc 2006;3:A213

Drugs

EvaluationDrugModalityDoseRoute
Comparator FSC 100/50mcg Unknown 50 ug Inhaled
Comparator Fluticasone propionate Other / unclassified 100 ug Inhaled
Comparator Fluticasone propionate Other / unclassified 250 ug Inhaled
Comparator Fluticasone propionate Other / unclassified 500 ug Inhaled

Indications